MBRX

Moleculin Biotech, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Klemp Walter VDirector, Officer: CEO And President
$250k675.7k shares
BuyJun 23, 2025
$0.37
--
Klemp Walter VDirector, Officer: CEO And President
$750k2M shares
BuyJun 23, 2025
$0.37
--
Foster Jonathan P.Chief Financial Officer
$100k270.3k shares
BuyJun 23, 2025
$0.37
--
Foster Jonathan P.Chief Financial Officer
$300k810.8k shares
BuyJun 23, 2025
$0.37
--

News

globenewswire.comIndependent Market Research Finds Strong Physician Intent to Prescribe Moleculin's Annamycin in Relapsed/Refractory AMLglobenewswire.comJun 5globenewswire.comMoleculin CEO, Walter Klemp, Highlights 45 Subject Enrollment Milestone in Recent Virtual Investor “What This Means” Segmentglobenewswire.comJun 4globenewswire.comMoleculin CEO, Walter Klemp, Highlights 45 Subject Enrollment Milestone in Recent Virtual Investor “What This Means” Segmentglobenewswire.comJun 4globenewswire.comMoleculin Presents ASCO 2026 Data Demonstrating No Detectable Cardiotoxicity with Annamycin Despite Exposure Levels Far Exceeding Conventional Anthracycline Limitsglobenewswire.comMay 29globenewswire.comMoleculin Presents ASCO 2026 Data Demonstrating No Detectable Cardiotoxicity with Annamycin Despite Exposure Levels Far Exceeding Conventional Anthracycline Limitsglobenewswire.comMay 29